Sporoderm‐broken spores of Ganoderma lucidum modulate hepatoblastoma malignancy by regulating RACK1 ‐mediated autophagy and tumour immunity
Journal of Cellular and Molecular Medicine · 2024-03 · 28 (6)
DOI: 10.1111/jcmm.18223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 07.03.2024. Verfasst von Rui Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Anhui University of Chinese Medicine, Hefei, China. Hauptthemen laut MEDLINE: Hepatoblastoma, Reishi, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Young Scholars Project of Natural Science Foundation of Anhui Province in China, Anhui Province Key Laboratory of Translational Cancer Research (Bengbu Medical College), Bengbu Medical College.
Abstract (Originalsprache)
Hepatoblastoma (HB), a primary liver tumour, is notorious for its high metastatic potential and poor prognosis. Ganoderma lucidum , an edible mushroom species utilized in traditional Chinese medicine for addressing various tumour types, presents an intriguing avenue for HB treatment. However, the effectiveness of G. lucidum in managing HB and its underlying molecular mechanism necessitates further exploration. Standard in vitro assays were conducted to evaluate the impact of sporoderm‐broken spores of G. lucidum (SBSGL) on the malignant characteristics of HB cells. The mechanism of SBSGL in treating HB and its tumour immunomodulatory effects were explored and validated by various experiments, including immunoprecipitation, Western blotting, mRFP‐GFP‐LC3 adenovirus transfection and co‐localization analysis, as well as verified with in vivo experiments in this regard. The results showed that SBSGL effectively inhibited the malignant traits of HB cells and suppressed the O‐GlcNAcylation of RACK1, thereby reducing its expression. In addition, SBSGL inhibited immune checkpoints and regulated cytokines. In conclusion, SBSGL had immunomodulatory effects and regulated the malignancy and autophagy of HB by regulating the O‐GlcNAcylation of RACK1. These findings suggest that SBSGL holds promise as a potential anticancer drug for HB treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School, Anhui University of Chinese Medicine, Hefei, China.
- School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
- Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, China.
ORCID-Profile: Hang Song
Förderung
- Excellent Young Scholars Project of Natural Science Foundation of Anhui Province in China
- Anhui Province Key Laboratory of Translational Cancer Research (Bengbu Medical College)
- Bengbu Medical College
Zitieren
APA
Shen, R., Ge, Y., Qin, Y., Gao, H., Yu, H., Wu, H., & Song, H. (2024). Sporoderm‐broken spores of Ganoderma lucidum modulate hepatoblastoma malignancy by regulating RACK1 ‐mediated autophagy and tumour immunity. Journal of Cellular and Molecular Medicine, 28(6). https://doi.org/10.1111/jcmm.18223
Vancouver
Shen R, Ge Y, Qin Y, Gao H, Yu H, Wu H, et al. Sporoderm‐broken spores of Ganoderma lucidum modulate hepatoblastoma malignancy by regulating RACK1 ‐mediated autophagy and tumour immunity. Journal of Cellular and Molecular Medicine. 2024;28(6). doi:10.1111/jcmm.18223
BibTeX
@article{Shen2024,
author = {Shen, Rui and Ge, Yang and Qin, Yunpeng and Gao, Hang and Yu, Hongyan and Wu, Huazhang and Song, Hang},
title = {Sporoderm‐broken spores of Ganoderma lucidum modulate hepatoblastoma malignancy by regulating RACK1 ‐mediated autophagy and tumour immunity},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {6},
doi = {10.1111/jcmm.18223}
}
EUVIMED